OPYT PRIMENENIYa PREPARATA LONGIDAZA U PATsIENTOK S NARUZhNYM GENITAL'NYM ENDOMETRIOZOM

Abstract

The results of the use of proteolytic enzyme longidaza in the combined treatment of pelvic endometriosis are presented in this study. The use of this drug leads to reduction of pain syndrome and adhesions, suppresses neoangiogenesis, decreases inflammatory reaction and development of fibroid tissue.

Full Text

##article.viewOnOriginalSite##